All Posts:prostate cancer
-
Men’s Event Celebrates 25 Years of Advances in Cancer Research
At the 25th anniversary of the Men’s Event, benefiting Georgetown University’s Lombardi Comprehensive Cancer Center, attendees celebrated the developments that have improved the prognosis for those diagnosed with the most prevalent types of men’s cancers, including advances in immunotherapy, precision medicine and minimally invasive surgery.
Category: Lombardi Stories
-
2023 Men’s Event Returns in Support of Cancer Research
More than 150 men gathered for the 23rd Annual Men’s Event to help raise money and awareness for cancer research in support of Georgetown University’s Lombardi Comprehensive Cancer Center.
Category: Lombardi Stories
-
Ralph Lauren Corporate Foundation Announces $25 Million Commitment to Five Cancer Centers Across America With Goal of Reducing Disparities in Cancer Care in Underserved Communities
Commitment Recognized by White House Cancer Moonshot Georgetown University to establish The Ralph Lauren Center for Cancer Prevention at Georgetown Lombardi Comprehensive Cancer Center in Washington, D.C. Memorial Sloan Kettering (MSK) Ralph Lauren Center to build upon 20-year partnership serving Harlem, New York, and surrounding communities Conquer Cancer®, the ASCO Foundation, to collaborate on the […]
Category: News Release
-
Cancer Organization Recommends Genetic Testing for Jewish People of Ashkenazi Descent
(January 28, 2020) — New guidelines from a leading cancer organization have broadened criteria for hereditary cancer genetic testing. The change means more people who could be at increased risk of developing cancer should consider being tested. The guidelines, released in December 2019 by the National Comprehensive Cancer Network, now indicate that all adult Ashkenazi […]
Category: Lombardi Stories
-
Continence Confidence: Prostatectomy Patients Reporting ‘Startling’ Success After Robotic Retzius-Sparing Surgery
A breakthrough method of prostate surgery known as Retzius-sparing is now eliminating continence issues for many men treated for prostate cancer at MedStar Georgetown University Hospital.
Category: Lombardi Stories
-
Carnegie Renews Classification of Georgetown as ‘Very High Research University’
Georgetown has once again been classified by the Carnegie Classification of Institutions of Higher Education as an institution with “very high research activity.”
Category: Lombardi Stories
-
Large Study Reveals Long-Term Outcomes for Prostate Cancer Patients Treated with High Dose, Short Term Radiation
A new study conducted at cancer centers around the country, including at Georgetown Lombardi Comprehensive Cancer Center, supports the routine use of a radiation treatment for prostate cancer that delivers a high dose of therapy in a very short time frame.
Category: News Release